The estimated Net Worth of Fady Ibraham Malik is at least $23.4 Milione dollars as of 3 September 2024. Fady Malik owns over 7,384 units of Cytokinetics Inc stock worth over $6,609,408 and over the last 12 years he sold CYTK stock worth over $15,233,535. In addition, he makes $1,580,630 as Executive Vice President - Research and Development at Cytokinetics Inc.
Fady has made over 74 trades of the Cytokinetics Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he sold 7,384 units of CYTK stock worth $420,962 on 3 September 2024.
The largest trade he's ever made was selling 32,605 units of Cytokinetics Inc stock on 9 April 2024 worth over $2,422,878. On average, Fady trades about 4,842 units every 33 days since 2012. As of 3 September 2024 he still owns at least 122,920 units of Cytokinetics Inc stock.
You can see the complete history of Fady Malik stock trades at the bottom of the page.
Dr. Fady Ibraham Malik is Executive Vice President - Research and Development of the Company. Dr. Malik has served as our Executive Vice President of Research and Development since November 2015. Dr. Malik served as our Senior Vice President of Research and Development from August 2014 to November 2015. Dr. Malik served as our Senior Vice President of Research and Early Development from June 2012 to August 2014. He has been with Cytokinetics since our inception in 1998, serving in a variety of roles, including Vice President, Biology from March 2008 to June 2012, all focused towards building our cardiovascular and muscle programs. Since 2000, Dr. Malik has held an appointment in the Cardiology Division of the University of California, San Francisco, where he is currently a Clinical Professor. He was also a practicing Interventional Cardiologist at the San Francisco Veterans Administration Medical Center for over 18 years. Dr. Malik received a B.S. from the University of California at Berkeley, a Ph.D. from the University of California at San Francisco and his M.D. from the University of California at San Francisco.
As the Executive Vice President - Research and Development of Cytokinetics Inc, the total compensation of Fady Malik at Cytokinetics Inc is $1,580,630. There are 1 executives at Cytokinetics Inc getting paid more, with Robert Blum having the highest compensation of $3,475,980.
Fady Malik is 55, he's been the Executive Vice President - Research and Development of Cytokinetics Inc since 2015. There are 18 older and 2 younger executives at Cytokinetics Inc. The oldest executive at Cytokinetics Inc is Dr. James A. Spudich Ph.D., 79, who is the Co-Founder & Member of Scientific Advisory Board.
Fady's mailing address filed with the SEC is 350, Oyster Point Boulevard, South San Francisco, San Mateo County, California, 94080, United States.
Over the last 21 years, insiders at Cytokinetics Inc have traded over $50,353,277 worth of Cytokinetics Inc stock and bought 879,922 units worth $7,454,506 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Capital Ltd Portfolio Servi... e Partners L P/Ilbiotechnolog.... On average, Cytokinetics Inc executives and independent directors trade stock every 14 days with the average trade being worth of $1,225,580. The most recent stock trade was executed by B Lynne Parshall on 9 September 2024, trading 5,000 units of CYTK stock currently worth $108,050.
cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. as a leader in muscle biology and the mechanics of muscle performance, we're developing small molecule drug candidates specifically engineered to increase muscle function and contractility.
Cytokinetics Inc executives and other stock owners filed with the SEC include: